Syeda Atiqa Batul, MD
Cardiovascular Disease · Scranton, PANPI 1326384868
Payments from drug & device makers
Across 150 payments — averaging $139.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$16K
- Medical Device Business Services, Inc.$1K
- Boston Scientific$1K
- Abbott$796
- Biosense Webster, Inc.$712
- Philips North America LLC$391
- plus $287 from 3 others
What the payments were for
- Consulting fees$1,1005%
- Speaking & faculty fees$5,91328%
- Travel & lodging$8,88942%
- Food & beverage$4,61722%
- Education$4642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 78 | $16,466 |
| Medical Device Business Services, Inc. | 5 | $1,264 |
| Boston Scientific | 36 | $1,067 |
| Abbott | 13 | $796 |
| Biosense Webster, Inc. | 11 | $712 |
| Philips North America LLC | 2 | $391 |
| Biotronik Inc. | 3 | $220 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $47 |
| Cordis US CORP. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$1,814
- EVERA MRI XT DR SURESCAN$737
- COBALT DR MRI SURESCAN$577
- (9520) IGT Devices Undivided$338
- AVEIR$243
- Micra$219
- GENERAL EP$213
- Edora$126
- BioMonitor$126
- Acticor$126
- Solia$126
- Rivacor$126
- RESONATE$121
- LUX-Dx Insertable Cardiac Monitor$104
How this compares
$20,984 in reported general payments places this provider in the 85th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 89 | $72,241 |
| Metoprolol Succinate | 260 | $5,854 |
| Flecainide Acetate | 37 | $1,027 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 21 | $919 |
| Amiodarone Hcl | 45 | $612 |
| Metoprolol Tartrate | 30 | $323 |
| Warfarin Sodium | 27 | $250 |
| Atorvastatin Calcium | 15 | $219 |
| Amlodipine Besylate | 32 | $149 |
| Pantoprazole Sodium | 11 | $147 |
| ClopidogrelClopidogrel Bisulfate | 13 | $145 |
| Losartan Potassium | 12 | $133 |
| Furosemide | 13 | $114 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Scranton
- Stephen VoyceScranton$412K
- Danielle DuffyPhiladelphia$29.5M
- Venkatesh NadarCamp Hill$18.3M
- Hemal GadaWormleysburg$6.7M
- Brian DrachmanPhiladelphia$3.8M
- William BachinskyMechanicsburg$2.3M
- Bonnie KyPhiladelphia$1.9M
- Benjamin KalsmithPgh$1.7M
- Marielle Scherrer CrosbiePhiladelphia$1.6M
- Paul GrenaYardley$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.